Gp100:209-217(210M)
Gp100:209-217(210M) is a peptide that is used in the field of oncology to stimulate the body's immune response against melanoma, a type of skin cancer. It is a modified version of a naturally occurring peptide, and is used in conjunction with other treatments to enhance their effectiveness.
Overview[edit | edit source]
Gp100:209-217(210M) is a peptide that is derived from the gp100 protein, which is expressed in melanoma cells. The peptide is modified at position 210 to enhance its ability to bind to HLA-A2, a molecule that is found on the surface of many human cells. This binding stimulates the immune system to recognize and attack melanoma cells.
Mechanism of Action[edit | edit source]
The mechanism of action of Gp100:209-217(210M) involves the stimulation of the body's immune response. The peptide binds to HLA-A2 molecules on the surface of cells, presenting it to T cells, a type of white blood cell. This triggers an immune response, with the T cells recognizing the peptide as foreign and attacking cells that express it. This includes melanoma cells, which express the gp100 protein from which the peptide is derived.
Clinical Use[edit | edit source]
Gp100:209-217(210M) is used in the treatment of melanoma, often in conjunction with other treatments such as chemotherapy or radiation therapy. It is administered as a vaccine, with the aim of stimulating the body's immune system to attack the cancer cells. Clinical trials have shown that it can enhance the effectiveness of these other treatments, leading to improved outcomes for patients.
Side Effects[edit | edit source]
As with any treatment, Gp100:209-217(210M) can have side effects. These can include fever, fatigue, and nausea. In some cases, the immune response it stimulates can also lead to autoimmune reactions, where the body's immune system attacks its own cells.
See Also[edit | edit source]
References[edit | edit source]
| Gp100:209-217(210M) Resources | |
|---|---|
 |
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
